Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Leap Therapeutics, Inc. (LPTX) since 2017 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Leap Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1509745.
Total stock buying since 2017: $40,495,922.
Total stock sales since 2017: $0.
Total stock option exercises since 2017: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 0 | $0 | 167,500 | $0 |
| 2024 | 0 | $0 | 0 | $0 | 27,500 | $0 |
| 2023 | 0 | $0 | 0 | $0 | 660,606 | $0 |
| 2021 | 2,543,800 | $7,249,830 | 0 | $0 | 0 | $0 |
| 2020 | 1,750,000 | $3,500,000 | 0 | $0 | 0 | $0 |
| 2019 | 2,285,712 | $3,999,996 | 0 | $0 | 0 | $0 |
| 2017 | 4,231,076 | $25,746,096 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-03 | 0 | $0 | 0 | $0 | 167,500 | $0 |
| 2024-01 | 0 | $0 | 0 | $0 | 27,500 | $0 |
| 2023-03 | 0 | $0 | 0 | $0 | 660,606 | $0 |
| 2021-09 | 2,543,800 | $7,249,830 | 0 | $0 | 0 | $0 |
| 2020-06 | 1,750,000 | $3,500,000 | 0 | $0 | 0 | $0 |
| 2019-02 | 2,285,712 | $3,999,996 | 0 | $0 | 0 | $0 |
| 2017-11 | 4,231,076 | $25,746,096 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-03-28 | Baum Jason (Chief Scientific Officer) | Option Ex | 22,500 | .00 | 0 |
| 2025-03-28 | Granfield Christine (VP, Head of Reg Affairs/Qual) | Option Ex | 22,500 | .00 | 0 |
| 2025-03-28 | O'mahony John Mark (Chief Manufacturing Officer) | Option Ex | 22,500 | .00 | 0 |
| 2025-03-28 | Sirard Cynthia (Chief Medical Officer) | Option Ex | 22,500 | .00 | 0 |
| 2025-03-28 | Onsi Douglas E (CEO,CFO,Pres.,GC,Treas.&Sec.) | Option Ex | 32,500 | .00 | 0 |
| 2025-03-28 | Lawlor Augustine (Chief Operating Officer) | Option Ex | 22,500 | .00 | 0 |
| 2025-03-28 | Mirabelli Christopher (Chairman of the Board) | Option Ex | 22,500 | .00 | 0 |
| 2024-01-26 | O'mahony John Mark (Chief Manufacturing Officer) | Option Ex | 5,000 | .00 | 0 |
| 2024-01-26 | Sirard Cynthia (Chief Medical Officer) | Option Ex | 5,000 | .00 | 0 |
| 2024-01-26 | Onsi Douglas E (CEO,CFO,Pres.,GC,Treas.,&Sec.) | Option Ex | 7,500 | .00 | 0 |
| 2024-01-26 | Lawlor Augustine (Chief Operating Officer) | Option Ex | 5,000 | .00 | 0 |
| 2024-01-26 | Mirabelli Christopher (Chairman of the Board) | Option Ex | 5,000 | .00 | 0 |
| 2023-03-17 | Onsi Douglas E (CEO,CFO,Pres.,GC,Treas.,&Sec.) | Option Ex | 660,606 | .00 | 0 |
| 2021-09-24 | Beigene, Ltd. | Buy | 2,543,800 | 2.85 | 7,249,830 |
| 2020-06-22 | Edelman Joseph (10% Owner) | Buy | 1,750,000 | 2.00 | 3,500,000 |
| 2019-02-05 | Healthcare Partners Ix, Llc (10% Owner) | Buy | 571,428 | 1.75 | 999,999 |
| 2019-02-05 | Onsi Douglas E (CFO, GC, Treasurer & Secretary) | Buy | 571,428 | 1.75 | 999,999 |
| 2019-02-05 | Lawlor Augustine (Chief Operating Officer) | Buy | 571,428 | 1.75 | 999,999 |
| 2019-02-05 | Mirabelli Christopher (CEO, President, Chairman) | Buy | 571,428 | 1.75 | 999,999 |
| 2017-11-14 | Healthcare Partners Ix, Llc (10% Owner) | Buy | 1,057,769 | 6.08 | 6,436,524 |
| 2017-11-14 | Onsi Douglas E (CFO, GC, Treasurer & Secretary) | Buy | 1,057,769 | 6.08 | 6,436,524 |
| 2017-11-14 | Lawlor Augustine (Chief Operating Officer) | Buy | 1,057,769 | 6.08 | 6,436,524 |
| 2017-11-14 | Mirabelli Christopher (CEO, President, COB) | Buy | 1,057,769 | 6.08 | 6,436,524 |
Insider trading activities including stock purchases, stock sales, and option exercises of LPTX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Leap Therapeutics, Inc. (symbol LPTX, CIK number 1509745) see the Securities and Exchange Commission (SEC) website.